Below you will find more information on clinical trials we are recruiting for as well as our current, on-going trials. If you have any
additional questions or would like to learn more about participating in one of our clinical trials please call 1-800-DIAL-EYE.

Upcoming Clinical Trials  

On-going Clinical Trials

• Diabetic Macular Edema (DME)- This condition occurs when fluid leaks into the center of the retina. The fluid can cause swelling
  of the retina and blurred vision. There is no pain associated with DME although early signs include blurred central vision. All 
  patients with diabetes are at risk for developing DME. John-Kenyon American Eye Institute is conducting several studies to
  help patients with this condition. To learn more about the different studies click on one of the options below.
  
  Degas Study - World-wide research study evaluating the safety and effectiveness of an investigational medication for DME. 
  Diabetic Retinopathy Clinical Research Network Study - Research study funded by the National Institute of Health evaluting the use of laser-treatment for DME patients. 
   

• Proliferative Diabetic Retinopathy - This condition occurs when there is abnormal blood vessel growth on the surface of your retina.   These new
  blood vessels can lead to serious vision problems because they can break and bleed into the vitreous, the clear, jelly-like substance that fills the
  center of the eye. Proliferative retinopathy is a much more serious form of diabetic retinopathy and can lead to blindness. The John-Kenyon American
  Eye Institute is committed to helping patients suffering from Proliferative Diabetic Retinopathy and is offering a clinical research study aimed to help
  patients suffering with the condition.

  Diabetic Retinopathy Clinical Research Network Study - Research study funded by the National Institute of Health evalutaing the use of 
  three potential treatments for DME.
  
  
• Age-Related Macular Degeneration (AMD) - Age-Related Macular Degeneration is the leading cause of adult blindness
  in the United States. The disease causes abnormal new blood vessels to grow in the back on the eye affecting the macula. Wet
  AMD can cause you to lose sharpness of vision and vision loss. This study will evaluate a new investigational medication to
  help stop or slow the progression of wet AMD related vision loss.
  Click here to learn more about this study.
   

 All information is available in Adobe Reader - if you do not have Adobe Reader click here to install.